Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide, Glargine, and Metformin Combination in Type 2 Diabetes
NCT00667732Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Mar 2007
- Primary completion
- Oct 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Oregon Health & Science University. Started Mar 2007; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00667732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00667732.